These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine. Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110 [TBL] [Abstract][Full Text] [Related]
5. Prothrombin gene expression in rat kidneys provides an opportunity to examine its role in urinary stone pathogenesis. Grover PK; Stapleton AM; Ryall RL J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S404-7. PubMed ID: 10541273 [TBL] [Abstract][Full Text] [Related]
6. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958 [TBL] [Abstract][Full Text] [Related]
7. Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence that a second hit is necessary for renal lithogenesis. Gambaro G; Valente ML; Zanetti E; Della Barbera M; Del Prete D; D'Angelo A; Trevisan A J Am Soc Nephrol; 2006 Aug; 17(8):2213-9. PubMed ID: 16790510 [TBL] [Abstract][Full Text] [Related]
8. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477 [TBL] [Abstract][Full Text] [Related]
9. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis. Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338 [TBL] [Abstract][Full Text] [Related]
10. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity. Grover PK; Ryall RL Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105 [TBL] [Abstract][Full Text] [Related]
12. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. Ryall RL; Chauvet MC; Grover PK BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927 [TBL] [Abstract][Full Text] [Related]
13. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model]. Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965 [TBL] [Abstract][Full Text] [Related]
14. The hole truth: intracrystalline proteins and calcium oxalate kidney stones. Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707 [TBL] [Abstract][Full Text] [Related]
17. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. Moriyama MT; Glenton PA; Khan SR J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956 [TBL] [Abstract][Full Text] [Related]
18. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. Thamilselvan S; Hackett RL; Khan SR J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin inhibits renal crystal retention in a rat stone forming model. Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815 [TBL] [Abstract][Full Text] [Related]
20. Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis. He Y; Chen X; Yu Z; Wu D; Lv Y; Shi S; Zhu H J Nephrol; 2004; 17(1):34-42. PubMed ID: 15151257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]